IKT-201

N/A

Report date: 2025/06/11 11:03:46

Base Information

Drug NameIKT-201
Drug Alias NamePD-L1 Checkpoint Inhibitor (Icell Kealex)IKT-201PD-L1-VV
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionProgrammed death-ligand 1 blockersImmunostimulantsT lymphocytes stimulants
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcell Kealex Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesIcell Kealex Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A